Ceravis AG takes over E-Vita GmbH
![](/en/press_media/Publikationen/annualreports/jahresbericht-2023-24/thema-00/jcr:content/contentPar/sectioncomponent/sectionParsys/textwithinlinedimage/imageComponent1/image.img.jpg/1724316536398/Allgemein-Jahresbericht-2023-24-Thema-00-Teaser-1.jpg)
The two founding shareholders of E-Vita GmbH, Ceravis AG and Fraunhofer-Gesellschaft e. V., announce that Ceravis has acquired all Fraunhofer shares in E-Vita with effect from June 30, 2023.
E-Vita GmbH was founded in 2021 by Ceravis and Fraunhofer as a joint venture to make the technology of chemical-free, sustainable treatment of seeds using electrons, which is already established in large-scale plants, economically viable for smaller seed quantities. The aim of the treatment is to eliminate bacteria, viruses and fungi on the surface of grains and other biological bulk goods.
Due to a strategic realignment of the business model by the management of E-Vita and the main shareholder Ceravis in the second half of 2022, the investment motive for Fraunhofer no longer applied, whereupon the shareholders of E-Vita mutually agreed to transfer the Fraunhofer shares to Ceravis and to terminate all contracts in connection with the originally planned development of the small-scale plants.
Ceravis, Fraunhofer and E-Vita will continue to cooperate in the field of electron treatment of seeds in the future.